Clinical trial
Cladribine Tablets: Observational Evaluation of Effectiveness and PROs in Suboptimally Controlled Patients Previously Taking Injectable DMDs for RMS (CLICK-MS)
NCT03933215 is registered in ClinicalTrials.gov with EMD Serono Research & Development Institute, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cladribine Tablets: Observational Evaluation of Effectiveness and PROs in Suboptimally Controlled Patients Previously Taking Injectable DMDs for RMS (CLICK-MS)
- Lead sponsor
- EMD Serono Research & Development Institute, Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 21, 2019
- Completion date
- March 30, 2024
- Enrollment
- 100 (actual)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.